The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Functional beta3-adrenoceptor in the human heart.
Open accessAbstract
Beta3-adrenoceptors are involved in metabolism, gut relaxation, and vascular vasodilation. However, their existence and role in the human heart have not been documented. We investigated the effects of several beta-adrenoceptor agonists and antagonists on the mechanical properties of ventricular endomyocardial biopsies. In the presence of nadolol, a beta1- and beta2-adrenoceptor antagonist, isoprenaline produced consistent negative inotropic effects. Similar negative inotropic effects also resulted from the action of beta3-adrenoceptor agonists with an order of potency: BRL 37344 > SR 58611 approximately CL 316243 > CGP 12177. The dose-response curve to BRL 37344-decreasing myocardial contractility was not modified by pretreatment with nadolol, but was shifted to the right by bupranolol, a nonselective beta-adrenoceptor antagonist. Beta3-adrenoceptor agonists also induced a reduction in the amplitude and an acceleration in the repolarization phase of the human action potential. Beta3-adrenoceptor transcripts were detected in human ventricle by a polymerase chain reaction assay. These results indicate that: (a) beta3-adrenoceptors are present and functional in the human heart; and (b) these receptors are responsible for the unexpected negative inotropic effects of catecholamines and may be involved in pathophysiological mechanisms leading to heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology nomenclature of adrenoceptors.
Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R., & Trendelenburg, U. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06780-8 · Cited by 1,218
Molecular Characterization of the Human β 3 -Adrenergic Receptor
Emorine, L. J., Marullo, S., Briend-Sutren, M.-M., Patey, G., Tate, K., Delavier-Klutchko, C., & Strosberg, A. D. (1989) · Science · doi:10.1126/science.2570461 · Cited by 1,088
Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs
Arch, J. R. S., Ainsworth, A. T., Cawthorne, M. A., Piercy, V., Sennitt, M. V., Thody, V. E., Wilson, C., & Wilson, S. (1984) · Nature · doi:10.1038/309163a0 · Cited by 728
Brodde, O. E. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06662-1 · Cited by 572
Tissue distribution of beta 3-adrenergic receptor mRNA in man
Krief, S., Lönnqvist, F., Raimbault, S., Baude, B., Van Spronsen, A., Arner, P., Strosberg, A. D., Ricquier, D., & Emorine, L. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116191 · Cited by 528
Xiao, R. P., Ji, X., & Lakatta, E. G. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08543-8 · Cited by 358
Beta-adrenoceptors in cardiac disease
Brodde, O.-E. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90030-h · Cited by 264
Structure, function, and regulation of adrenergic receptors
Strosberg, A. D. (1993) · Protein Science · doi:10.1002/pro.5560020802 · Cited by 248 · cited 2×
“b 3 -adrenoceptor shares only 40–50% amino acid sequence identity with b 1 - and b 2 -adrenoceptors, possesses an intron whereas b 1 - and b 2 -adrenoceptors are intronless (2), and lacks recognition sites for the cAMPdependent and b -adrenoceptor kinases implicated in the desensitization of b 2 -adrenoceptors (3).”
BackgroundCoexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species
Langin, D., Portillo, M. P., Saulnier-Blache, J.-S., & Lafontan, M. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90492-9 · Cited by 205
Self-citationIs there a third heart β-adrenoceptor?
Kaumann, A. J. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90065-5 · Cited by 179
Langin, D., Laurell, H., Holst, L. S., Belfrage, P., & Holm, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4897 · Cited by 155
Self-citationBond, R. A., & Clarke, D. E. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11698.x · Cited by 150
Distribution of β3-adrenoceptor mRNA in human tissues
Berkowitz, D. E., Nardone, N. A., Smiley, R. M., Price, D. T., Kreutter, D. K., Fremeau, R. T., & Schwinn, D. A. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90098-5 · Cited by 149
Evidence for a functional β3‐adrenoceptor in man
Lönnqvist, F., Krief, S., Strosberg, A. D., Nyberg, SS., Emorine, L. J., & Arner, P. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13902.x · Cited by 149
Is the adipocyte β-adrenoceptor a prototype for the recently cloned atypical ‘β3-adrenoceptor?’
Zaagsma, J., & Nahorskii, S. R. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90032-4 · Cited by 147
Characterization of the human beta 3-adrenergic receptor gene.
Granneman, J. G., Lahners, K. N., & Chaudhry, A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13147-7 · Cited by 113
Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle.
del Monte, F., Kaumann, A. J., Poole-Wilson, P. A., Wynne, D. G., Pepper, J., & Harding, S. E. (1993) · Circulation · doi:10.1161/01.cir.88.3.854 · Cited by 107
Differential interaction of β1- and β3-adrenergic receptors with Gi in rat adipocytes
Chaudhry, A., MacKenzie, R. G., Georgic, L. M., & Granneman, J. G. (1994) · Cellular Signalling · doi:10.1016/0898-6568(94)90093-0 · Cited by 101
Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines.
Dolan, J. A., Muenkel, H. A., Burns, M. G., Pellegrino, S. M., Fraser, C. M., Piétri‐Rouxel, F., Strosberg, A. D., Largis, E. E., Dutia, M. D., & Bloom, J. D. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38827-0 · Cited by 81
Cardiac effects of the beta 3‐adrenoceptor agonist BRL35135 in man.
Wheeldon, N., McDevitt, D., & Lipworth, B. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04290.x · Cited by 45
The phenylethanolaminotetralines: New selective agonists for atypical β-adrenoceptors
Manara, L., & Bianchetti, A. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90247-6 · Cited by 43
Pharmacological characteristics and species‐related variations of β3‐adrenergic receptors
Piétri‐Rouxel, F., & Strosberg, A. D. (1995) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00288.x · Cited by 43
Involvement of β3-Adrenoceptor in the Relaxation Response in Guinea Pig Taenia Caecum
Koike, K., Takayanagi, I., Muramatsu, M., Ohki, S., & Horinouchi, T. (1994) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.66.213 · Cited by 27
The potential significance of beta 3 adrenergic receptors.
Lowell, B. B., & Flier, J. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117798 · Cited by 17
Cited by
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
Vascular Adrenoceptors: An Update
Guimarães, S., & Moura, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01495-9 · Cited by 700
Adrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
Catecholamines and the Effects of Exercise, Training and Gender
Zouhal, H., Jacob, C., Delamarche, P., & Gratas-Delamarche, A. (2008) · Sports Medicine · doi:10.2165/00007256-200838050-00004 · Cited by 553
Metadata
- Authors
- Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., & Le Marec, H.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-07-15
- Volume
- 98
- Issue
- 2
- Pages
- 556-562
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2046610430
- Cited by
- 461
- References
- 24
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.